Key facts
- Plant People’s last known valuation is $55.0M (Dec 2025).
- It has raised $7.9M across 1 recorded rounds; the latest was Early Stage VC ($7.9M) in Nov 2025.
- Notable investors include Chaos Ventures (New York), Unilever Ventures, Artemis Growth Partners, JourneyOne Ventures, Manna Tree — 6 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Plant People
Funding rounds
1 roundsAbout Plant People
Producer of practitioner-grade herbal, mushroom and CBD products intended to unlock botanical intelligence to reconnect people with their true nature. The company's supplements are organic, non-GMO, vegan hemp and herbal drops, capsules and balms with full-spectrum CBD that improve sleep, anxiety, mental focus and everyday aches and pains, enabling users to heal and connect through the power of plants.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Austin, TX, United States
- Founded
- 2017
- Employees
- 24
- Website
- plantpeople.co/
- Ownership
- Privately Held (backing)
Plant People doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Plant People shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Plant People in its N-PORT filings yet. We sweep new filings monthly.